These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 23995423)

  • 1. Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica.
    Ratelade J; Asavapanumas N; Ritchie AM; Wemlinger S; Bennett JL; Verkman AS
    Acta Neuropathol; 2013 Nov; 126(5):699-709. PubMed ID: 23995423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity.
    Duan T; Smith AJ; Verkman AS
    Acta Neuropathol Commun; 2019 Jul; 7(1):112. PubMed ID: 31296268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.
    Ratelade J; Zhang H; Saadoun S; Bennett JL; Papadopoulos MC; Verkman AS
    Acta Neuropathol; 2012 Jun; 123(6):861-72. PubMed ID: 22526022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic cleavage of anti-aquaporin-4 autoantibody in neuromyelitis optica by an IgG-selective proteinase.
    Tradtrantip L; Asavapanumas N; Verkman AS
    Mol Pharmacol; 2013 Jun; 83(6):1268-75. PubMed ID: 23571414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity-matured 'aquaporumab' anti-aquaporin-4 antibody for therapy of seropositive neuromyelitis optica spectrum disorders.
    Duan T; Tradtrantip L; Phuan PW; Bennett JL; Verkman AS
    Neuropharmacology; 2020 Jan; 162():107827. PubMed ID: 31654702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica.
    Ratelade J; Smith AJ; Verkman AS
    Exp Neurol; 2014 May; 255():145-53. PubMed ID: 24636863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic neuritis in neuromyelitis optica.
    Levin MH; Bennett JL; Verkman AS
    Prog Retin Eye Res; 2013 Sep; 36():159-71. PubMed ID: 23545439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica.
    Soltys J; Liu Y; Ritchie A; Wemlinger S; Schaller K; Schumann H; Owens GP; Bennett JL
    J Clin Invest; 2019 Apr; 129(5):2000-2013. PubMed ID: 30958797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G.
    Yao X; Verkman AS
    Acta Neuropathol Commun; 2017 Feb; 5(1):15. PubMed ID: 28212662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59.
    Zhang H; Verkman AS
    J Autoimmun; 2014 Sep; 53():67-77. PubMed ID: 24698947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica.
    Zhang H; Verkman AS
    J Clin Invest; 2013 May; 123(5):2306-16. PubMed ID: 23563310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique neuromyelitis optica pathology produced in naïve rats by intracerebral administration of NMO-IgG.
    Asavapanumas N; Ratelade J; Verkman AS
    Acta Neuropathol; 2014 Apr; 127(4):539-51. PubMed ID: 24190619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays.
    Phuan PW; Ratelade J; Rossi A; Tradtrantip L; Verkman AS
    J Biol Chem; 2012 Apr; 287(17):13829-39. PubMed ID: 22393049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.
    Tradtrantip L; Zhang H; Saadoun S; Phuan PW; Lam C; Papadopoulos MC; Bennett JL; Verkman AS
    Ann Neurol; 2012 Mar; 71(3):314-22. PubMed ID: 22271321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G.
    Asavapanumas N; Ratelade J; Papadopoulos MC; Bennett JL; Levin MH; Verkman AS
    J Neuroinflammation; 2014 Jan; 11():16. PubMed ID: 24468108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica.
    Tradtrantip L; Yao X; Su T; Smith AJ; Verkman AS
    Acta Neuropathol; 2017 Jul; 134(1):35-44. PubMed ID: 28567523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica.
    Ratelade J; Verkman AS
    Mol Immunol; 2014 Nov; 62(1):104-13. PubMed ID: 24980869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica.
    Phuan PW; Zhang H; Asavapanumas N; Leviten M; Rosenthal A; Tradtrantip L; Verkman AS
    Acta Neuropathol; 2013 Jun; 125(6):829-40. PubMed ID: 23677375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica.
    Tradtrantip L; Felix CM; Spirig R; Morelli AB; Verkman AS
    Neuropharmacology; 2018 May; 133():345-353. PubMed ID: 29428821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
    Mader S; Gredler V; Schanda K; Rostasy K; Dujmovic I; Pfaller K; Lutterotti A; Jarius S; Di Pauli F; Kuenz B; Ehling R; Hegen H; Deisenhammer F; Aboul-Enein F; Storch MK; Koson P; Drulovic J; Kristoferitsch W; Berger T; Reindl M
    J Neuroinflammation; 2011 Dec; 8():184. PubMed ID: 22204662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.